期刊
NATIONAL SCIENCE REVIEW
卷 8, 期 9, 页码 -出版社
OXFORD UNIV PRESS
DOI: 10.1093/nsr/nwaa286
关键词
metallodrug; cancer therapy; mitochondrial targeting; bio-orthogonally catalyzed lethality; bio-orthogonal reaction
资金
- National Natural Science Foundation of China [21420102002, 21771109, 21731004, 21807060, 22077066, 22025701]
- China Postdoctoral Science Foundation [2019M651874]
Through a bio-orthogonally catalyzed lethality (BCL) strategy, a targeting anti-tumor metallodrug Ru-rhein was successfully generated and demonstrated significant anti-tumor efficacy in vitro and in vivo. This strategy could also be extended to other metal complexes for potential cancer treatment applications.
Synthetic lethality was proposed nearly a century ago by geneticists and recently applied to develop precision anti-cancer therapies. To exploit the synthetic lethality concept in the design of chemical anti-cancer agents, we developed a bio-orthogonally catalyzed lethality (BCL) strategy to generate targeting anti-tumor metallodrugs both in vitro and in vivo. Metallodrug Ru-rhein was generated from two non-toxic species Ru-N-3 and rhein-alkyne via exclusive endogenous copper-catalyzed azide alkyne cycloaddition (CuAAC) reaction without the need of an external copper catalyst. The non-toxic species Ru-arene complex Ru-N-3 and rhein-alkyne were designed to perform this strategy, and the mitochondrial targeting product Ru-rhein was generated in high yield (>83%) and showed high anti-tumor efficacy in vitro. This BCL strategy achieved a remarkable tumor suppression effect on the tumor-bearing mice models. It is interesting that the combination of metal-arene complexes with rhein via CuAAC reaction could transform two non-toxic species into a targeting anti-cancer metallodrug both in vitro and in vivo, while the product Ru-rhein was non-toxic towards normal cells. This is the first example that exclusive endogenous copper was used to generate metal-based anti-cancer drugs for cancer treatment. The anti-cancer mechanism of Ru-rhein was studied and autophagy was induced by increased reactive oxygen species and mitochondrial damage. The generality of this BCL strategy was also studied and it could be extended to other metal complexes such as Os-arene and Ir-arene complexes. Compared with the traditional methods for cancer treatment, this work presented a new approach to generating targeting metallodrugs in vivo via the BCL strategy from non-toxic species in metal-based chemotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据